ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
Oric Pharmaceuticals (NASDAQ:ORIC) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Oric Pharmaceuticals (NASDAQ:ORIC) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: You Angie
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Kunkel Lori Anne
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Hoerter Steven L.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.